Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.83B | 1.83B | 1.54B | 1.48B | 1.07B |
Gross Profit | 487.39M | 501.95M | 414.45M | 471.26M | 284.58M |
EBITDA | 160.68M | 53.50M | 237.57M | 266.08M | -97.78M |
Net Income | -203.70M | -194.21M | 49.52M | 75.07M | -258.45M |
Balance Sheet | |||||
Total Assets | 4.13B | 4.50B | 4.75B | 4.73B | 4.58B |
Cash, Cash Equivalents and Short-Term Investments | 1.40B | 1.24B | 1.20B | 1.89B | 1.82B |
Total Debt | 357.62M | 456.94M | 475.02M | 117.97M | 139.88M |
Total Liabilities | 746.56M | 881.82M | 896.09M | 504.94M | 456.51M |
Stockholders Equity | 2.98B | 3.24B | 3.49B | 3.86B | 3.81B |
Cash Flow | |||||
Free Cash Flow | 206.11M | 229.79M | -5.46M | 151.00M | 3.75M |
Operating Cash Flow | 244.83M | 247.53M | 31.73M | 170.95M | 39.05M |
Investing Cash Flow | 164.29M | -20.95M | 587.77M | -261.67M | -742.86M |
Financing Cash Flow | -235.72M | -151.07M | -518.45M | -90.80M | -93.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | HK$665.44M | 40.04 | 1.07% | 8.00% | -1.20% | -87.51% | |
66 Neutral | HK$1.64B | 5.08 | 24.13% | 4.37% | -3.85% | -19.28% | |
54 Neutral | HK$1.53B | 130.77 | -1.93% | 1.62% | -6.00% | -232.11% | |
54 Neutral | HK$1.22B | 46.20 | 1.27% | ― | -4.30% | 13.83% | |
51 Neutral | $7.86B | -0.26 | -41.41% | 2.22% | 22.87% | -2.01% | |
48 Neutral | HK$1.76B | ― | -4.66% | 0.46% | -0.55% | 45.36% | |
48 Neutral | HK$934.19M | ― | -10.78% | ― | -0.95% | -128.35% |
Town Health International Medical Group Ltd. announced that all resolutions at their Annual General Meeting were approved, including the adoption of financial statements and the declaration of a final dividend. Additionally, Ms. Lau Suk Hing Clara was appointed to the Nomination Committee, reflecting a strategic move in the company’s governance structure.
Town Health International Medical Group Ltd. announced the composition of its board of directors and the roles within its board committees. This update reflects the company’s governance structure, which is crucial for maintaining transparency and accountability in its operations, potentially impacting stakeholder confidence and the company’s strategic direction.